Search Results
Comment: PARP inhibitor olaparib plus bevacizumab in women with ovarian cancer
Dr. Hardesty on Bevacizumab/PARP Inhibitor Combination in Ovarian Cancer
PARP inhibitor rechallenging in ovarian cancer
Anne talks about ovarian cancer and drug olaparib
Maintenance Therapy in Ovarian Cancer
Precision Medicine for Ovarian Cancer (2021)
Implications of PAOLA-1 in Advanced Ovarian Cancer
Dr. Mirza on Efficacy of Niraparib/Bevacizumab Combo in Recurrent Ovarian Cancer
Sequencing PARP Inhibitors in Advanced Ovarian Cancer
PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat
Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer
The PARP Revolution: How PARP inhibitors are changing the landscape of ovarian cancer treatment